Interleukin-6 attenuates the development of experimental diabetes-related neuropathy.

Neuropathy is the most severe and the least understood complication of diabetes. We investigated the potential neuroprotective effect of IL-6 therapy in an experimental model of diabetic neuropathy. A single i.